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Abstract
Noroviruses are important human pathogens responsible for most cases of viral epidemic gastroenteritis worldwide. Murine
norovirus-1 (MNV-1) is one of several murine noroviruses isolated from research mouse facilities and has been used as a
model of human norovirus infection. MNV-1 infection has been shown to require components of innate and adaptive
immunity for clearance; however, the initial host protein that recognizes MNV-1 infection is unknown. Because noroviruses
are RNA viruses, we investigated whether MDA5 and TLR3, cellular sensors that recognize dsRNA, are important for the host
response to MNV-1. We demonstrate that MDA52/2 dendritic cells(DC) have a defect in cytokine response to MNV-1. In
addition, MNV-1 replicates to higher levels in MDA52/2 DCs as well as in MDA52/2 mice in vivo. Interestingly, TLR32/2
DCs do not have a defect in vitro, but TLR32/2 mice have a slight increase in viral titers. This is the first demonstration of an
innate immune sensor for norovirus and shows that MDA5 is required for the control of MNV-1 infection. Knowledge of the
host response to MNV-1 may provide keys for prevention and treatment of the human disease.
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Introduction
Norwalk virus and other human noroviruses are common human
pathogens responsible for most of the nonbacterial epidemic
gastroenteritis in both developed and developing countries
[1,2,3,4,5]. In humans, norovirus infection can result in vomiting,
diarrhea, fever, malaise, and abdominal pain within 24 hours after
infection. These symptoms usually clear within 48 hours, but the
virus can persist asymptomatically for 3–6 weeks post-infection
[6,7]. Until recently the inability to culture human noroviruses has
prevented investigation into its pathogenicity. The discovery and
subsequent routine culture of murine norovirus-1 (MNV-1) has led
to advances in understanding of both the norovirus lifecycle as well
as the host response to norovirus infection [8,9].
Noroviruses are in the Calicivirus family and are nonenveloped
viruses containing a single-stranded positive-sense RNA genome.
Norovirus genomes are covalently linked at the 59 end to a viral
nonstructural protein VPg [10]. Norovirus genomes encode three
open reading frames (ORFs) [11,12,13,14]. ORF1 encodes a
polyprotein that is cleaved into at least six nonstructural proteins
by the viral 3C-like protease [15,16,17,18]. ORF2 encodes the
major capsid protein, viral protein 1 [11,19], while ORF3 encodes
the small basic protein, viral protein 2 [20,21]. An additional
ORF, ORF4 was recently discovered in the MNV genome
although the function of this ORF has yet to be characterized [14].
The rapid clearance of MNV-1 infection in immunocompetent
mice indicates an important role for the innate immune system,
since clearance precedes the timeframe normally associated with
the initiation of adaptive immunity [22]. Previous work has
revealed that MNV-1 infection of mice lacking either the type I
and type II interferon (IFNa/b/c) receptors or the STAT-1
molecule results in lethality [9,22]. Several proteins are known to
initiate the IFN response to viruses [23], including Toll-like
receptors (TLR) [24], Rig-I-like helicases (RLH) [25,26], PKR
[27], and RNase L [28]. However, the initial sensor responsible for
recognition of noroviruses and subsequent activation of cytokine
response has not been determined.
TLRs are located on the plasma membrane and in endosomal
compartments. Among the TLRs, TLR 7 and 8 recognize ssRNA
[29,30,31], TLR9 recognizes DNA [32,33], while TLR3 signals in
response to dsRNA [34]. The RLHs are sensors located within the
cytoplasm [26], which include Rig-I and MDA-5 [23,35,36] and
signal through IPS-1/MAVS/Cardiff/VISA [37,38,39,40]. Rig-I
has recently been shown to preferentially recognize 59-phosphor-
ylated RNA [41,42], while MDA5 responds to dsRNA [43].
Recently it has been shown that the lack of Rig-I does not confer
susceptibility to human norovirus in vitro [44]. Because MDA5
[45,46,47,48], and TLR3 [49,50] have been shown to play a role in
host response to other RNA viruses we investigated if these sensors
might be involved in norovirus recognition in vitro and in vivo using
the MNV-1 model system. In this study we demonstrate that indeed
MDA5is the predominant sensor of MNV-1and initiatesthe innate
immune response against the virus, and that TLR3 may also play a
role in the response to MNV-1 in certain tissues.
Results
MDA-5 is required for cytokine response to MNV-1 by
Bone Marrow-Derived DC
Previous studies have shown a requirement for the type I IFN
response for control of MNV-1 infection in vitro [8]. Since both
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cytokine signaling in response to infection with other RNA viruses, we
were interested to see if they may play a role in MNV-1 infection.
MNV-1 infection has a limited cell tropism- infecting only DC
and macrophage lineages in vitro [8,51]. In order to test whether
the MDA5 or TLR3 sensors were important, BMDCs from Wild
Type as well as TLR32/2 and MDA52/2 mice were cultured
for 7 days and then inoculated with various MOI of MNV-1. After
24 hours supernatants from the in vitro infections were harvested
and tested for cytokine secretion from the BMDCs.
Interestingly, although WT and TLR3 DCs produced similar
levels of IFNa and inflammatory cytokines in response to MNV
stimulation, MDA5 deficient DCs produced significantly less
IFNa, IL-6, MCP-1, TNFa (Figure 1) and IFNb (data not shown).
In this cell type MDA5 appears to be the primary sensor
responsible for type 1 IFN production in response to MNV-1,
however, we cannot rule out that other sensors may play a role in
other cell types.
MDA5 limits MNV-1 replication in vivo
MNV-1 infection naturally occurs after fecal-oral transmission
[8]. In order to test whether MDA5 and TLR3 play a role in MNV-
1 detection in vivo we infected WT, MDA52/2, or TLR32/2
mice with MNV-1.CW3 perorally. Organs were then harvested
from infected as well as mock-infected mice on days 1, 3, and 5 after
inoculation and viral titers were determined for each sample.
MNV-1 titers were highest at d3 post infection. At this time-
point MDA52/2 animals had significantly increased viral titers
compared to wild type animals in the mesenteric lymph nodes,
spleen, and proximal intestine (Figure 2). Minimal or no virus titers
was detected by plaque assay in the distal intestine or feces (data
not shown) in WT and MDA52/2 animals on the 129/Svj
background. Interestingly, although there did not appear to be an
effect of TLR3 deficiency in the detection of MNV-1 in vitro, there
was a slight, but significant increase in viral titers in the mesenteric
lymph node of TLR32/2 mice compared to wild type mice. No
difference in virus titers was detected in the spleen or distal
intestine between WT and TLR32/2 animals (Figure 2). This
may indicate a role for TLR3 in MNV-1 detection in a tissue-
specific manner. Minimal or negative titers were seen in proximal
intestines and feces (data not shown) in WT and TLR32/2
animals on the B6 background. That B6 and 129 strains of mice
have higher titers of virus in the distal and proximal intestine
respectively has been reported in previous studies [14,22] and may
reflect the differential distribution of viral sensors along the
gastrointestinal tract.
Previous work has demonstrated that lack of innate immune
components leads to disseminated MNV-1 infection and is
ultimately fatal [9]. Therefore we determined whether the lack
of MDA5 could also cause a more extensive spread of MNV-1.
However, we detected no virus titers in the lung or the liver in WT
or MDA52/2 mice (data not shown). Consistent with the lack of
systemic infection, serum samples taken from WT and MDA52/
2 mice at 1, 3, and 5 days after inoculation were tested by ELISA
for IFNa, IFNb, and IFNc and found to be negative (data not
shown). The kinetics of clearance of MNV-1 infection was similar
in WT and MDA52/2 mice in vivo, even though there was a
significant increase in virus titers in the MDA52/2 animals at
day 3. By day 5 post-inoculation no virus titers were detected in
MDA52/2 spleen, MLN, or proximal intestine. In addition,
there was no difference in survival between WT, MDA52/2,o r
TLR32/2 mice for 35 days post-inoculation. In contrast, STAT-
12/2 mice and IFNabcR2/2 mice have shown a survival
defect to MNV-1 infection. Since these mice have complete
abrogation of IFN signaling pathways, this may indicate that
MDA5 and TLR3 are redundant or that other sensors may also
play a role in MNV-1 detection.
MNV-1 replicates more efficiently in MDA-5 deficient DCs
Because the MDA52/2 and TLR32/2 mice had an increase
in MNV-1 virus titers, we wanted to test the cellular basis of this
deficiency. To address this issue, we infected BMDCs from WT,
MDA52/2, and TLR32/2 mice with MNV-1 and harvested
samples at 6-hour time-points after inoculation. The infections
were done at a high and low MOI to test for effects on viral
replication and spreading.
Viral titers were identical in WT, MDA52/2, and TLR32/2
mice up to 12 hours after inoculation at the high MOI (Figure 3a).
However, starting at 18 hours pi, titers from MDA52/2 BMDCs
began to increase over WT and TLR32/2 BMDCs, and leveled
out to a significant difference at 24 and 48 hours, indicating that
MDA5 recognition occurs late in viral infection. At a low MOI
there was no significant difference between viral titers in WT and
MDA52/2 cells until the 48 hour time-point (Figure 3b),
indicating that the requirement for MDA5 recognition requires
multiple cycles of replication. Indeed, the peak level of IFN
production in WT BMDCs occurs at 12 hours post-infection after
a low MOI inoculation (Figure 3d), suggesting that a cycle of viral
replication is necessary to induce IFNb. The increase in virus titers
in the MDA52/2 cells reflects the defect in type I IFN produced
in response to viral infection. IFN pretreatment of MDA52/2
BMDCs before infection with a low MOI reconstitutes the WT
phenotype, preventing an increase in virus titers.
In both MOIs the kinetics of MNV-1 infection appears similar
in WT and MDA52/2 BMDCs; the difference mainly appears to
be in the total amount of viral replication seen in the MDA52/2
BMDCs. Interestingly, although TLR32/2 mice had an increase
in MNV-1 titers, TLR32/2 BMDCs had no significant increase
in titers. This may reflect a cell type-specific role for viral sensors.
MDA-5 recognizes replication competent viral RNA
Although we have demonstrated that MDA5 is required to
recognize MNV-1, it is unclear which RNA feature is essential for
recognition. Another sensor, Rig-I, recognizes viruses mainly
through 59-phosphorylation, however, in noroviruses this feature is
absent because of a 59 VPg cap [10]. To test whether 59 RNA
configuration is essential for MDA5 recognition we purified viral
RNA from MNV-1 virions. BMDCs from WT, MDA5, or TLR3
Author Summary
Gastroenteritis is a common disease in both developed
and developing countries. The two main causes of this
affliction are bacteria and viruses. The primary viruses
implicated in gastroenteritis have been shown to be
noroviruses, which include Norwalk virus, notorious for
numerous recent outbreaks on cruise ships. We are
interested in how the innate immune system detects viral
infection and prepares the host to respond to the threat.
To understand how the host responds to norovirus
infection, we studied two classes of proteins, both of
which are thought to detect signs of viral infection. We
discovered that one of these proteins, melanoma differ-
entiation associated protein-5 (MDA-5), is responsible for
detecting a mouse norovirus that is genetically related to
the human pathogen. These findings allow us to better
understand the pathogenesis of norovirus infection and
may provide clues for controlling the human disease.
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well as RNA treated with RNase A which degrades ssRNA, and
proteinase K (PK), which degrades proteins- in this case the VPg
cap. As expected, RNase treatment degraded the viral RNA, while
PK treatment did not degrade the RNA as seen in Figure 4a.
Consistent with the results of in vitro MNV-1 infections shown in
Figure 1, both WT and TLR32/2 BMDCs produced type 1 IFN
in response to purified viral RNA, while MDA52/2 BMDCs had
a significant decrease in IFN response (Figure 4b,c). However, the
addition of PK or RNase to the RNA abrogated the cytokine
response in WT and TLR32/2 BMDCs. This data demonstrates
that VPg is required for MDA5 recognition of MNV-1, and
suggests that MDA5 either directly recognizes RNA linked to VPg
or, since VPg is required for norovirus replication [44], that
MDA5 recognizes dsRNA generated during viral replication.
Because MDA5 has been previously shown to recognize uncapped
poly I:C [46,47], it is most likely that the result of PK treatment
reflects the requirement for viral replication and the subsequent
generation of dsRNA that is recognized by MDA5. Consistent
with this hypothesis, WT BMDCs inoculated with UV-inactivated
MNV-1 did not produce IFNb (data not shown).
Discussion
We have provided the first description of an initial sensor of
norovirus infection. MDA5 recognizes MNV-1 and stimulates
antigen presenting cells to produce type I interferon as well as IL-
6, MCP-1, and TNFa that function to recruit other immune cells
as well as activate antiviral pathways in host cells. Deficiency of
this sensor results in lack of cytokine production as well as
increased MNV-1 replication in deficient cells and mice.
It is interesting to note that although MDA5 deficient cells have
a severe defect in IFNa production, MDA52/2 mice contain and
clear MNV-1 infection. This is in contrast the severe systemic
infection and survival phenotype as the IFNabcR or STAT1
deficient mice, which lack type I and type II IFN signaling
pathways. STAT-12/2 and IFNabcR2/2 mice have a 4 log
increase in viral titers in vivo and a 2 log increase in viral titers in
vitro as seen in previously published data [22]. In our study
MDA52/2 mice have a 1-log increase in viral titers in vivo and in
vitro, while TLR32/2 mice have a 0.5 log increase, but only in
one organ in vivo. This indicates to us that although MDA5 may be
the dominant sensor in BMDCs, it is likely that in other cell types
additional sensors can detect MNV-1, such as Rig-I, PKR, TLR7,
and perhaps other unknown sensors. Further investigation is
needed to determine if mice and cells that are deficient in multiple
nucleic acid sensors lack all ability to respond to MNV-1 and
whether they therefore have a more severe phenotype. Data from
our lab and others [44] from in vitro experiments suggest that lack
of TLR3 and Rig-I seem to have little effect on MNV-1
recognition individually, however, we cannot rule out that their
involvement is masked by MDA5.
Although the putative recognition structure for Rig-I has
previously been determined [41,42], the RNA structure recog-
Figure 1. MDA5 is required for cytokine response to MNV in vitro. Bone marrow-derived dendritic cells from wild type (WT), TLR3 deficient
(TLR3 KO), or MDA5 deficient (MDA5 KO) mice were infected in vitro with MNV at the indicated MOI. Cell culture supernatants were harvested
24 hours after inoculation, and examined for IFNa by ELISA (A) or for IL-6 (B), MCP-1 (C), or TNFa (D) by cytokine bead array. Data shown is the
average of three independent experiments. Statistical analysis was done using student’s t test where *=p,0.05, **=p,0.01, and ***=p,0.001.
doi:10.1371/journal.ppat.1000108.g001
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demonstrated that MDA5 recognition of MNV RNA is abrogated
by treatment with PK, which degrades VPg, preventing viral
replication. This data suggests that VPg is essential for MDA5
recognition of MNV-1. Although we cannot rule out the possibility
that MDA5 recognizes the VPg-RNA structure itself, this is less
likely because MDA5 is known to respond to poly I:C which has
no protein cap. It is more likely that since VPg is essential for viral
replication of the ssRNA norovirus genome, loss of VPg prevents
MDA5 recognition of dsRNA produced during viral replication.
Learning more about which viruses are recognized by MDA5 may
provide hints as to what this protein recognizes. This information
could then be used to design adjuvants to manipulate the immune
response for both vaccine design as well as in treatment of viral
infection.
Materials and Methods
Cell lines
RAW264.7 cells were maintained in Dulbecco modified Eagle
medium (DMEM) supplemented with 10% fetal calf serum
(Hyclone), 100 U penicillin/ml, 100 mg/ml streptomycin,
10 mM HEPES, and 2 mM L-glutamine.
Viruses
All experiments were performed with MNV-1.CW3 [14]. Virus
stocks were generated using RAW 264.7 cells that were inoculated
with a multiplicity of infection (MOI) of 0.05 in VP-SFM media
(Gibco) and harvested approximately 40 hours after inoculation.
Infected cell lysates were frozen at 280uC and thawed three times.
Cell lysates were clarified by low-speed centrifugation for 20 min
at 3,000 rpm. To generate a concentrated virus stock, clarified cell
lysates were concentrated by centrifugation at 4uC for 3 h at
27,000 rpm (90,000 g) in a SW32 rotor.
Bone marrow-derived DC
Bone marrow was flushed from the femurs of mice and cultured
as described previously [52]. Briefly, cells were cultured in RPMI
(Gibco) with 10% fetal calf serum (Hyclone), Glutamax, Na
Pyruvate, Non-Essential AAs, and Kanamycin for 7–8 days at 37
degrees.
Figure 2. MNV replicates more efficiently in MDA5 and TLR3 KOs in vivo. Wild type (129 or B6), MDA52/2 (MDA5), or TLR32/2 (TLR3) mice
were inoculated perorally with 3610
7 PFU MNV-1.CW3 or mock infected with media only. Organs were harvested 3 days after infection and viral titers
of Spleen (A), Mesenteric Lymph Node (MLN) (B), Proximal Intestine (C), and Distal Intestine (D) were determined by plaque assay. Statistical
significance was calculated using the Mann Whitney test, where ***=p,0.001, *=p,0.05. Mock-infected animals showed no detectable MNV-1 at all
time-points tested. Data shown is from 6–9 animals. Dashed line indicates limit of detection of the assay.
doi:10.1371/journal.ppat.1000108.g002
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MDA52/2 mice were described previously [47]. For the
infection studies mice backcrossed onto a pure 129/SVJ back-
ground wereused.ControlWT micewereage andsexmatchedand
were obtained from littermate controls and from Jackson Lab for
129/SVJ and C57BL/6. TLR32/2 mice were kindly provided by
Richard Flavell [34]. All mice were bred and housed in a pathogen
free facility and regularly tested for MNV-1 antibodies.
In vitro stimulations
BMDCs were counted and plated at 200,000 cells/well in a 96
well plate. MNV-1 was added at various MOI to the cultures, or
alternatively 500 ng RNA was complexed with lipofectamine 2000
(invitrogen) and added according to manufactures instructions.
After 20–24 hours supernatants were harvested and stored at 220
degrees until cytokine analysis. IFNa and IFNb levels from the
supernatants were measured by ELISA (PBL Biomedical Labora-
tory, New Brunswick, NJ), while IL-6, MCP-1, and TNFa levels
were determined by cytokine bead array (BD Biosciences).
In vivo infections
WT, TLR32/2, or MDA52/2 mice were infected perorally
with 3610
7 PFU MNV1.CW3 [14] or mock-infected with media
only. Three days post-infection the following organs were
harvested and stored at 280 degrees until assayed: spleen, liver,
mesenteric lymph node, lung, proximal intestine, distal intestine,
stool, and serum.
MNV-1 plaque assay
Tissue samples were homogenized in 1 ml complete DMEM by
bead beating with 1.0-mm zirconia/silica beads (BioSpec
Products, Inc.). Tissue homogenates were diluted 1:10 in complete
DMEM and tested for viral titers by using a plaque assay that has
been previously described [8]. Briefly, 2610
6 RAW264.7 cells
were seeded into each well of six-well plates, and infected the next
day with 10-fold dilutions of tissue homogenate in duplicate. After
a 1-hr infection, the inoculum was removed and wells were
overlaid with 1.5% SeaPlaque agarose (Cambridge Biosciences) in
complete minimal essential medium and incubated at 37uC. After
48 hrs, a second overlay was added containing 1.5% SeaKem
agarose (Cambridge Biosciences) and 0.01% neutral red in
complete minimal essential medium. After 8 hrs, plaques were
then visualized.
RNA preparation
Total viral RNA was harvested from concentrated virus stock
using Trizol reagent (Invitrogen) according to manufacturer’s
instructions. Purified RNA was incubated with either 10 units
RNase A (Sigma) in NEB buffer 3 (New England Biolabs) or with
200 mg/ml proteinase K (Sigma) in 0.1 M NaCl, 10 mM Tris
Figure 3. MDA5 deficiency leads to increased MNV titers in vitro. Bone marrow-derived dendritic cells from wild type (WT), MDA52/2,o r
TLR32/2 mice were inoculated with MNV at an MOI of 5 (A) or 0.05 (B) or pre-treated with 20 U IFNa and then inoculated with an MOI of 0.05 (C).
Viral titers were done at 6 hour time-points for each sample and statistical significance was determined using student’s t test. There was no significant
difference between WT and TLR32/2 titers, statistical significance is marked between WT and MDA52/2 titers where *=p,0.05. Data shown is the
average of four independent experiments (A and B) or three independent experiments (C). In (D) supernatants from WT BMDC infected at MOI 0.05
were harvested at various time-points and tested for IFNb by ELISA. Data shown is the average of three independent experiments.
doi:10.1371/journal.ppat.1000108.g003
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untreated in NEB buffer 3 for 30 minutes at 37uC then stopped
with 0.1 mM EDTA. To test for RNA degradation, samples were
run on a 1% agarose gel and visualized using a UV light box.
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